Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis
Authors
Keywords
Thalassemia, Osteoporosis, DKK-1, Strontium ranelate, Sclerostin
Journal
JOURNAL OF BONE AND MINERAL METABOLISM
Volume 34, Issue 5, Pages 540-546
Publisher
Springer Nature
Online
2015-07-24
DOI
10.1007/s00774-015-0689-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate
- (2015) A. Catalano et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials
- (2014) Andrea Giusti JOURNAL OF BONE AND MINERAL METABOLISM
- Thalassemia Bone Disease: A 19-Year Longitudinal Analysis
- (2014) Phillip Wong et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis
- (2013) Maurizio Rossini et al. CALCIFIED TISSUE INTERNATIONAL
- Strontium ranelate: in search for the mechanism of action
- (2013) Jan J. Stepan JOURNAL OF BONE AND MINERAL METABOLISM
- Zoledronic Acid Acutely Increases Sclerostin Serum Levels in Women With Postmenopausal Osteoporosis
- (2013) Antonino Catalano et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men
- (2013) J.-M. Kaufman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
- (2012) E. Voskaridou et al. HORMONE AND METABOLIC RESEARCH
- Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells
- (2012) M. Doyard et al. OSTEOPOROSIS INTERNATIONAL
- An Akt-dependent Increase in Canonical Wnt Signaling and a Decrease in Sclerostin Protein Levels Are Involved in Strontium Ranelate-induced Osteogenic Effects in Human Osteoblasts
- (2011) Mark S. Rybchyn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
- (2011) E. T. Middleton et al. OSTEOPOROSIS INTERNATIONAL
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- (2011) J-Y. Reginster et al. OSTEOPOROSIS INTERNATIONAL
- An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
- (2010) Pierre J. Marie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis
- (2010) P. J. Marie et al. OSTEOPOROSIS INTERNATIONAL
- The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study
- (2008) Ibrahim Gulhan et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started